Veritikug (upb-101) matching solution for subcutaneous injection with no active treatment, Verekitug (UPB-101) clinical trials

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of Verekitug (UPB-101) in Participants with Chronic Rhinosinusitis with Nasal Polyps on a Background of Nasal Corticosteroids (VIBRANT)

This study is testing a new medicine, Verekitug, for people with long-term stuffy nose and nasal polyps, which are soft growths inside the nose. We want to see if it helps reduce polyps and other symptoms.